You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA methyltransferase inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

O6-methylguanine-DNA Methyltransferase Promoter Methylation and

Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
May 14, 2021

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

HBV Reactivation Between High HBV-DNA and Low HBV-DNA Loads

Recruiting
  • Hepatocellular Carcinoma
  • ICI
  • Antiviral Prophylaxis
  • Guangzhou, Guangdong, China
  • +3 more
Jan 4, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Advanced Cancer Trial in Belgium, France (AsiDNA)

Completed
  • Advanced Cancer
  • Bruxelles, Belgium
  • +4 more
Mar 23, 2022

Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)

Recruiting
  • Immunotherapy
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 2, 2021

Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA=4000 Copy/ml Trial in Guangzhou (Toripalimab, IMRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Yanqun Xiang
Feb 7, 2022

OPTImal PALliative Anti-epidermal Growth Factor Receptor

Active, not recruiting
  • Colorectal Cancer Metastatic
  • +5 more
  • Plasma circulating DNA analysis
  • Aarhus, Denmark
    Aarhus University Hospital
Feb 24, 2022

Advanced MTAP-null Solid Tumors Trial in Worldwide (AMG 193, Docetaxel)

Recruiting
  • Advanced MTAP-null Solid Tumors
  • Duarte, California
  • +17 more
Aug 11, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023